EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 6-Nov-2025 02:11 ET (6-Nov-2025 07:11 GMT/UTC)

Research spotlight: Implantable “CANDI” wafer shows promise for preventing glioblastoma recurrence

Mass General Brigham
Peer-Reviewed Publication

Yannik Kaiser, MD-candidate, and Ralph Weissleder, MD, PhD, of the Center for Systems Biology at Massachusetts General Hospital and Harvard Medical School are the lead and corresponding authors of a paper published in Nature Biomedical Engineering, “Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence.”

Journal: Nature Biomedical Engineering
Funder: National Institute of Health Sciences, Swiss Institute for Experimental Cancer Research, German Academic Exchange Service

Johns Hopkins-led study finds drugs approved for treating pain also reduce bone cancer growth

Johns Hopkins Medicine
Peer-Reviewed Publication

A multicenter research team led by Johns Hopkins Medicine reports that two analgesic drugs, bupivacaine and rimegepant, not only relieve tumor-associated pain in laboratory mice, but also slow the unchecked growth of osteosarcomas.

Journal: Proceedings of the National Academy of Sciences
Funder: National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health (NIH), National Institute of Neurological Disorder and Stroke at NIH, National Institute of Dental and Craniofacial Research at NIH, National Institutes of Health, Department of Defense

Targeted radiation during surgery reduces pancreatic cancer recurrence

Johns Hopkins Medicine
Peer-Reviewed Publication

Using targeted radiation during surgery — referred to as intraoperative radiation — to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce the recurrence rate around the pancreas to 5%. This is believed to be the lowest ever reported for this population of patients, according to a preliminary study by the team from the Johns Hopkins Kimmel Cancer Center.

Journal: International Journal of Radiation Oncology*Biology*Physics

MD Anderson’s top nurses receive The Brown Foundation Award for Excellence in Oncology Nursing

University of Texas M. D. Anderson Cancer Center
Grant and Award Announcement

The University of Texas MD Anderson Cancer Center yesterday honored Kimberly Vanderhorst, MSN, RN, CAPA, and Terri Lynn Dunn, DNP, APRN, WHNP-BC, CPHQ, with the 2025 Brown Foundation Award for Excellence in Oncology Nursing. As the institution’s highest nursing honor, this award celebrates outstanding achievements in oncology nursing, including exceptional patient care and a commitment to excellence in clinical practice.

Leading the way in targeted cancer treatment

University of Missouri-Columbia
Peer-Reviewed Publication

In the quest for more targeted lung cancer treatments, a researcher at the University of Missouri thinks the solution may lie in tiny bubble-shaped packages that cells use to talk to each other.

Journal: Molecular Therapy Oncology

Dicer: Life's ancient repair tool

Cold Spring Harbor Laboratory
Peer-Reviewed Publication

CSHL Professor & HHMI Investigator Rob Martienssen has found that both the Dicer protein and RNase H enzyme are needed to fully resolve conflicts between DNA transcription and replication. The discovery could have significant implications for how we think about cancer and the origins of life.

Journal: Molecular Cell
Funder: NIH/National Institutes of Health, Howard Hughes Medical Institute, Institut Curie, Centre National de la Recherche Scientifique, Agence Nationale de la Recherche, Ligue Contre le Cancer

UT Health San Antonio recognized among nation’s top 100 oncology programs

The University of Texas at San Antonio Health Science Center
Business Announcement

UT Health San Antonio’s Mays Cancer Center has been named among the nation’s leading hospitals and health systems for excellence in oncology programs, according to Becker’s Hospital Review.

AI tool identifies women at high risk of interval breast cancer

Radiological Society of North America
Peer-Reviewed Publication

In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancers, breast cancer that is diagnosed between regular screening mammograms.

Journal: Radiology

Global initiative to demonstrate operational excellence in Nigeria for metastatic colorectal cancer patients

Hiltzik Strategies
Business Announcement

Today, the Innovative Cancer Medicines (ICM) initiative announced the enrollment of the first Nigerian patient in a pioneering demonstration project to provide an immunotherapy drug used to treat cancer. The goal of the initiative is to develop an approach that explores sustainable and effective administration of innovative immuno-oncology therapies in low- and middle-income countries.

Gene–environment interaction of GWAS loci and reproductive history in uterine fibroid risk

Xia & He Publishing Inc.
Peer-Reviewed Publication

Uterine fibroids (UFs) are common hormone-dependent tumors with a complex etiology involving both genetic and environmental factors. This study aimed to investigate, for the first time, the associations between loci from genome-wide association studies (GWAS) and environmental risk factors in UF development, with a particular focus on gene–environment interactions.

Journal: Gene Expression

8
9
10
11
12